Top Headlines
- Glaxosmithkline, Novartis ink 'supercomplex' $26.65B deal in a three-way transaction
- Valeant $45B Allergan bid clever, but will board go along?
- Oncothyreon halts at Sentinel's checkpoint: Deal worth up to $174M
- Principia lands $50M series B to support a leap to the clinic
- FDA finalizes a 15-year-old sameness map for orp...
Latest News
Analysis
When cancers become resistant to the drugs used to treat them, it has become possible – at least in principle – to understand the cause of that resistance through sequencing, and if a drug exists that is effective against cells with the mutation, to change a patient's treatment accordingly. But a better strategy might be to prevent resistance from developing at all.
Our Habitat for All Things Science
Weight loss surgery may work mainly through biochemical effects
More than 150,000 Americans undergo weight loss surgery annually. But according to a new study, it may be possible to ditch the scalpel but still reap the benefits of the procedure, either through drugs or even, possibly, changes to the diet.
READ MORE »- A prostaglandin synthesis inhibitor that's good for the heart »
- Nanotechnology: Scientific promise meets business perils »
- Bridging big data valley of death that comes before valley of death »
- Gene therapy success in mouse model of neurodegenerative disease »
- Palbociclib shows PFS but not (yet?) OS benefit in phase II »
- Flu vaccine candidate protects against multiple viruses »
- In some cases, more to Alzheimer’s than just amyloids »
- ‘Completely new’ cancer treatment strategy will start clinical trials in 2015 »
- Study reveals complex view of diabetes »
Featured Report
Opinion
- Hamburg: Society needs to weigh inApril 10, 2014 | 7:10 PM | Posted by: Mari Serebrov
- Bear hunting with biotech’s naysayersApril 08, 2014 | 7:37 PM | Posted by: Peter Winter
- Rock to the left, hard place to the right: One dilemma of compassionate useMarch 13, 2014 | 4:16 PM | Posted by: Jennifer Boggs
- Human germline engineering: The mom’s not in the pictureMarch 04, 2014 | 3:17 PM | Posted by: Anette Breindl
- Biosimilar regulation: 1984 v. 2014February 19, 2014 | 9:06 PM | Posted by: Mari Serebrov
